141A — Trial Holdings Income Statement
0.000.00%
Last trade - 00:00
- ¥418bn
- ¥344bn
- ¥720bn
- 86
- 47
- 88
- 91
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Tanshin |
Standards: | JAS | JAS | JAS | — |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 157,934 | 597,689 | 655,478 | 720,441 |
Cost of Revenue | ||||
Gross Profit | 29,060 | 112,273 | 127,637 | 144,845 |
Selling / General / Administrative Expenses | ||||
Research And Development | ||||
Depreciation and Amortization | ||||
Unusual Expense / Income | ||||
Other Operating Expenses | ||||
Total Operating Expenses | 156,494 | 586,332 | 641,835 | 702,806 |
Operating Profit | 1,440 | 11,357 | 13,643 | 17,635 |
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | 2,489 | 12,029 | 14,067 | 18,693 |
Provision for Income Taxes | ||||
Net Income After Taxes | 1,960 | 7,560 | 8,473 | 11,838 |
Minority Interest | ||||
Net Income Before Extraordinary Items | ||||
Net Income | 1,847 | 7,136 | 8,086 | 11,440 |
Adjustments to Net Income | ||||
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | 1,846 | 7,135 | 8,084 | 11,439 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | 19.5 | 63.9 | 69.8 | 118 |
Dividends per Share |